Short answer
LENZ Therapeutics, Inc. (LENZ) filed an 8-K current report with the SEC on July 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Zach Scheiner resigned from the Board and all committees effective June 30, 2026.
LENZ Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Zach Scheiner resigned from the Board and all committees effective June 30, 2026
- Resignation unrelated to disputes over company operations, policies, or practices
- Board reduced to six directors, narrowing governance capacity
- Jeff George appointed to the Audit Committee, preserving three-member committee composition
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LENZ Therapeutics, Inc. 8-K filings
Get the next LENZ 8-K as it lands
Follow LENZ for push alerts, or ask the research agent what this filing means.